Premium
Granulocyte activation during haemodialysis in the absence of complement activation: inhibition by calcium channel blockers
Author(s) -
HAAGWEBER MARIANNE,
SCHOLLMEYER P.,
HÖRLy W. H.
Publication year - 1988
Publication title -
european journal of clinical investigation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.164
H-Index - 107
eISSN - 1365-2362
pISSN - 0014-2972
DOI - 10.1111/j.1365-2362.1988.tb01027.x
Subject(s) - diltiazem , verapamil , nifedipine , calcium channel , medicine , calcium , lactoferrin , pharmacology , bepridil , granulocyte , endocrinology , calcium channel blocker , chemistry , biochemistry
The effect of the calcium channel blockers nifedipine (9 and 18 μ g kg ‐1 h ‐1 ), diltiazem (100 and 200 μ g kg ‐1 h ‐1 ) and verapamil (19 μ g kg ‐1 h ‐1 ) continuously infused during haemodialysis on granulocyte and complement activation was investigated. Plasma levels of lactoferrin, elastase in complex with α 1 ‐proteinase inhibitor (E‐ α 1 PI) and C3a were measured in patients dialysed with dialysers made of cuprophane, polymethylmethacrylate (PMMA) and polyacrylonitrile (PAN). Calcium channel blockers caused no change of blood pressure during haemodialysis in all patients. There was no effect of nifedipine, diltiazem or verapamil on plasma lactoferrin, E‐ α 1 PI or C3a levels in patients dialysed with cuprophane. However, plasma lactoferrin and E‐ α 1 PI values were significantly reduced by all calcium channel blockers in patients dialysed with PMMA, and also by nifedipine and verapamil in patients dialysed with PAN. Our data indicate that calcium channel blockers inhibit granulocyte activation occurring in dialysers with very little anaphylatoxin formation. These drugs, however, are ineffective in patients dialysed with cuprophane where complement activation takes place. Therefore, granulocyte activation during haemodialysis in the absence of complement activation seems to be mediated by calcium ions.